CIK 0001810182
- Non-accelerated filer
- Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 850642577
- Phone
- +1 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- 4 Grant or award SVP, Finance and CAO acquired 26,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 32,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 89,000 shares (grant or award)
- 4 Open-market sale VP, Finance and CAO sold 7,345 shares at $6.52 ($47,889)
- 4 Open-market sale Chief Medical Officer sold 1,605 shares at $7.34 ($11,781)
- 4 Open-market sale President & CEO sold 3,208 shares at $7.34 ($23,547)
- 4 Open-market sale VP, Finance and CAO sold 466 shares at $7.34 ($3,420)
- 4 Open-market sale Chief Financial Officer sold 887 shares at $7.34 ($6,511)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Medical Officer acquired 12,829 shares (option exercise)
- 4 Open-market sale VP, Finance and CAO sold 482 shares at $11.07 ($5,336)
- 4 Open-market sale Chief Medical Officer sold 1,617 shares at $11.07 ($17,901)
- 4 Open-market sale Chief Financial Officer sold 893 shares at $11.07 ($9,886)
- 4 Open-market sale President & CEO sold 3,232 shares at $11.07 ($35,779)
- 4 Exercise or conversion Chief Medical Officer acquired 46,474 shares (option exercise)
Page 6 of 11 · 213 filings